Updated Jul 16, 2026
Hoeiland Jesper has filed 1 SEC Form 4 filing across 1 company in the last 90 days.
Jesper Hoeiland is identified in the SEC filings as a Director of Allarity Therapeutics, Inc. as of May 11, 2026. Beyond this director role, publicly available SEC documentation does not provide a detailed professional history. Due to the limited scope of the provided SEC context, there is insufficient public biographical information to assert a broader biography.
| Role | Director |
|---|---|
| Notability | 12/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-11 | ALLR | Allarity Therapeutics, Inc. | A — Grant or award | 25.0K | $0.00 |
Jesper Hoeiland is identified in the SEC filings as a Director of Allarity Therapeutics, Inc. as of May 11, 2026. Beyond this director role, publicly available SEC documentation does not provide a detailed professional history. Due to the limited scope of the provided SEC context, there is insufficient public biographical information to assert a broader biography.…
1 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Hoeiland Jesper profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.